ArticleMaterials today. Bio2026
Injectable thermosensitive hydrogel incorporating exosome-loaded chitosan microspheres for immunomodulation and cartilage regeneration.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic inflammation and impaired immune microenvironment are key barriers to effective cartilage regeneration. Herein, we developed an integrated, injectable thermosensitive hydrogel system termed CS@Gel-Mg. This system modularly combines exosome-loaded chitosan microspheres (CM@Exo) embedded within a Mg Methods: Hydroxypropyl-modified chitosan microspheres were synthesized via emulsion crosslinking and effectively loaded with bioactive exosomes. The Gel matrix was fabricated using an ionic liquid monomer (IL-C4) copolymerized with NIPAM and N-vinylimidazole, followed by Mg Results: In vitro, the system demonstrated excellent cytocompatibility, promoted ATDC5 cell proliferation and migration, and inhibited apoptosis. The hydrogel also reprogrammed macrophage polarization from M1 to M2 phenotype, as confirmed by qPCR and flow cytometry. In vivo, using a rat full-thickness cartilage defect model, CS@Gel-Mg exhibited improved weight-bearing function, reduced inflammatory infiltration, and superior cartilage histological scores compared to control groups. Mechanistically, immunofluorescence and Western blot analyses suggested enhanced expression of SOX9, COL2A1 and COL1A1, along with suppression of inflammatory cytokines. Furthermore, SOX9 knockdown in vivo diminished the therapeutic effect, confirming its regulatory role in the immuno-chondrogenic axis. Conclusion: This exosome-integrated thermoresponsive hydrogel provides a multifunctional platform for immune modulation and cartilage regeneration. Our findings highlight the potential of CS@Gel-Mg as a promising therapeutic strategy for osteochondral repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.